| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000034697 |
| Receipt No. | R000039530 |
| Scientific Title | Evaluation of mitochondrial function by 99m Tc-MIBI in patients with heart failure. |
| Date of disclosure of the study information | 2018/11/01 |
| Last modified on | 2020/05/19 (Ver. 5) |
| Basic information | ||
| Public title | Evaluation of mitochondrial function by 99m Tc-MIBI in patients with heart failure. | |
| Acronym | Evaluation of mitochondrial function by 99m Tc-MIBI in patients with heart failure. | |
| Scientific Title | Evaluation of mitochondrial function by 99m Tc-MIBI in patients with heart failure. | |
| Scientific Title:Acronym | Evaluation of mitochondrial function by 99m Tc-MIBI in patients with heart failure. | |
| Region |
|
|
| Condition | ||
| Condition | heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigated the relationship between 99mTc-MIBI and exercise capacity in patients with acute decompensated heart failure six months after a discharge and a discharge.
|
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To investigated the relationship between 99mTc-MIBI and exercise capacity in patients with acute decompensated heart failure six months after a discharge and a discharge. |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 99mTc-MIBI and exercise tolerance | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Improvement of acute signs and symptoms of heart failure. | |||
| Key exclusion criteria | Patient with severe aortic stenosis and mitral stenosis.
Patients under dialysis. Patients with chronic lung disease. Patients following stroke with neurological deficit. Patients with severe liver cirrhosis and failure. Patients with life-threatening malignancy. |
|||
| Target sample size | 50 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University School of Medicine | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 113-8431 | ||||||
| Address | 3-1-3 Hongo Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| tkatou@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University School of Medicine | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 113-8431 | ||||||
| Address | 3-1-3 Hongo Bunkyo-ku, Tokyo | ||||||
| TEL | 03-3813-3111 | ||||||
| Homepage URL | |||||||
| tkatou@juntendo.ac.jp | |||||||
| Sponsor | |
| Institute | Juntendo University School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ministry of Education, Culture, Sports, Science and Technology |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Department of Cardiovascular Medicine, Juntendo University School of Medicine |
| Address | 3-1-3, Hongo, bunkyo-ku, Tokyo |
| Tel | 0338133111 |
| tkatou@juntendo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000039530 |